Trial Profile
A Single-Centre, Retrospective Cohort Study Assessing the Safety and Efficacy of Simeprevir and Sofosbuvir in Patients with Hepatitis-C Infection from a Federally Qualified Health Center [FQHC]
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Nov 2017
Price :
$35
*
At a glance
- Drugs Simeprevir (Primary) ; Sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 16 Nov 2017 New trial record
- 24 Oct 2017 Results presented at The Liver Meeting 2017: 68th Annual Meeting of the American Association for the Study of Liver Diseases